What is Vera Therapeutics's change in AP?

Vera Therapeutics (VERA) reported change in AP of -$7.97M in Q1 2026.

How has Vera Therapeutics's change in AP changed year-over-year?

Vera Therapeutics's change in AP decreased by 598.8% year-over-year, from $1.6M to -$7.97M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Vera Therapeutics VERA Change in AP

Change in AP at other companies

Vertex PharmaceuticalsVRTX

$35.6M+35.9%

Travere Therapeutics, Inc.TVTX

-$11.81M-42.2%

Aurinia PharmaceuticalsAUPH

-$652K+33.1%

Nektar TherapeuticsNKTR

-$934K-115%

Viridian Therapeutics, Inc.VRDN

$4.63M+162%

ImmunomeIMNM

$1.42M+137%

Other financials

Income statement

See full

Operating income-$125.1M-119%

Net income-$121.0M-134%

EPS (diluted)-$1.69-109%

Balance sheet

See full

Cash & equivalents$114.4M+108%

Total debt$75.0M+37.8%

Total equity$499.7M-6.6%

Total assets$621.7M+1.9%

Cash flow

See full

Operating cash flow-$106.5M-95.8%

CapEx$23.0K-87.7%

Free cash flow-$106.5M-95.1%

Valuation

See full

Market cap$2.74B+87.5%

Enterprise value$2.7B+85.0%

Returns & leverage

See full

Return on equity-71.3%+296pp

Debt / equity0.2×0.0×

Current ratio13.6×-14.0×

Where this comes from

Reported directly by Vera Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vera Therapeutics's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vera Therapeutics's change in AP?: Vera Therapeutics (VERA) reported change in AP of -$7.97M in Q1 2026.
How has Vera Therapeutics's change in AP changed year-over-year?: Vera Therapeutics's change in AP decreased by 598.8% year-over-year, from $1.6M to -$7.97M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.